HLA-B27 testing in Thai patients using the PCR-SSP technique

O Nathalang1, S Tantimavanich, K Nillakupt

  • 1Department of Pathology, Phramongkutklao College of Medicine, Bangkok, Thailand. oytipnti@hotmail.com

Tissue Antigens
|April 1, 2006
PubMed

Insights

A new Polymerase Chain Reaction Sequence Specific Primer (PCR-SSP) test kit for HLA-B27 was developed. This cost-effective kit demonstrates high accuracy, making it a valuable tool for clinical diagnostics.

Area of Science:

  • Immunogenetics
  • Molecular Diagnostics

Background:

  • The Human Leukocyte Antigen B27 (HLA-B27) gene is associated with various autoimmune diseases.
  • Accurate and efficient detection of HLA-B27 is crucial for diagnosis and patient management.

Purpose of the Study:

  • To develop and validate a Polymerase Chain Reaction Sequence Specific Primer (PCR-SSP) based test kit for the detection of HLA-B27.
  • To evaluate the performance of the developed PCR-SSP kit compared to the gold standard microlymphocytotoxicity test (LCT).

Main Methods:

  • Development of an in-house HLA-B27 test kit utilizing the PCR-SSP technique.
  • Testing of 540 blood samples using both the newly developed PCR-SSP kit and the established LCT method.

Main Results:

  • The PCR-SSP method identified 134 (24.8%) HLA-B27 positive samples, compared to 127 (23.5%) by LCT.
  • The PCR-SSP kit demonstrated high sensitivity (94.8%) and perfect specificity (100%) against the LCT method.
  • Excellent concordance (98.7%), positive predictive value (100%), and negative predictive value (98.3%) were observed for the PCR-SSP test.

Conclusions:

  • The developed PCR-SSP test kit is a simple, convenient, and cost-effective method for HLA-B27 detection.
  • PCR-SSP offers a reliable alternative for in-house HLA-B27 testing in clinical laboratories.
  • This validated kit can aid in the timely diagnosis of HLA-B27 associated conditions.

Related Concept Videos